Literature DB >> 27419685

[Effectiveness of heparin versus 0.9% saline solution in maintaining the permeability of central venous catheters: a systematic review].

Eduardo José Ferreira Dos Santos1, Maria Madalena Jesus Cunha Nunes2, Daniela Filipa Batista Cardoso1, João Luís Alves Apóstolo1, Paulo Joaquim Pina Queirós1, Manuel Alves Rodrigues1.   

Abstract

OBJECTIVE: Determining which is the most effective solution (heparin flush compared to 0.9% saline flush) for reducing the risk of occlusions in central venous catheters (CVC) in adults.
METHOD: The systematic review followed the principles proposed by the Cochrane Handbook; critical analysis, extraction and synthesis of data were performed by two independent researchers; statistical analysis was performed using the RevMan program 5.2.8.
RESULTS: Eight randomized controlled trials and one cohort study were included and the results of the meta-analysis showed no difference (RR=0.68, 95% CI=0.41-1.10; p=0.12). Analysis by subgroups showed that there was no difference in fully deployed CVC (RR=1.09, CI 95%=0.53-2.22; p=0.82); Multi-Lumen CVC showed beneficial effects in the heparin group (RR=0.53, CI 95%=0.29-0.95; p=0.03); in Double-Lumen CVC for hemodialysis (RR=1.18, CI 95%=0.08-17.82; p=0.90) and Peripherally inserted CVC (RR=0.14, CI 95%=0.01-2.60; p=0.19) also showed no difference.
CONCLUSION: Saline solution is sufficient for maintaining patency of the central venous catheter, preventing the risks associated with heparin administration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27419685     DOI: 10.1590/S0080-623420150000600017

Source DB:  PubMed          Journal:  Rev Esc Enferm USP        ISSN: 0080-6234            Impact factor:   1.086


  3 in total

Review 1.  Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.

Authors:  Lei Zhong; Hai-Li Wang; Bo Xu; Yao Yuan; Xin Wang; Ying-Ying Zhang; Li Ji; Zi-Mu Pan; Zhan-Sheng Hu
Journal:  Crit Care       Date:  2017-01-08       Impact factor: 9.097

Review 2.  Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients.

Authors:  Francisca Jane Gomes de Oliveira; Andrea Bezerra Rodrigues; Islane Costa Ramos; Joselany Áfio Caetano
Journal:  Rev Lat Am Enfermagem       Date:  2020-06-19

3.  Direct cost of maintenance of totally implanted central venous catheter patency.

Authors:  Rafael Fernandes Bel Homo; Antônio Fernandes Costa Lima
Journal:  Rev Lat Am Enfermagem       Date:  2018-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.